This guidance shall apply to the approval/certification of the manufacturing/import, review of technical documents, and approval of clinical trial protocols for a DTx that provide evidence-based therapeutic intervention to patients for preventing, managing, or treating medical disorders or diseases.

Note : This guideline was previously titled 'Guideline on Review and Approval of Digital Therapeutics (For Industry)'.